Choksi Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2026 ,inter alia, to consider and approve 1. To consider and approve ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Choksi Laboratories has called a board meeting on 7 February 2026 at 12:30 PM. The main item on the agenda is the approval of unaudited financial results for the quarter ended 31 December 2025 (Q3 FY26). The board will also appoint Mr. Ritik Pavecha (DIN: 08790431) as an Additional Independent Director from 7 February 2026. Additionally, the board will formally record the resignation of Mrs. Meenaxi Patidar (DIN: 10206356) as Independent Director, effective 9 January 2026. The trading window for dealing in the company's shares remains closed and will reopen 48 hours after the Q3 results are declared.
Investors should watch for the Q3 FY26 earnings release on or shortly after 7 February 2026, which will be the key driver of near-term stock movement. A change in the independent director lineup is a routine governance update and not material to financials.